Vrbková Jana Ph.D.

Journals

BOUCHALOVÁ, K., M. SVOBODA, G. KHARAISHVILI, J. VRBKOVÁ, J. BOUCHAL, R. TROJANEC, V. KOUDELÁKOVÁ, L. RADOVÁ, K. CWIERTKA, M. HAJDÚCH, Z. KOLÁŘ
BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy. Tumor Biology. 2015, 36(6), 4243-52, ISSN: 1010-4283, PMID: 25616695,
SZOTKOWSKI, T., E. FABER, J. HUBACEK, L. RAIDA, P. ROHON, A. KUBA, Z. PIKALOVA, M. HOLZEROVA, M. DIVOKÁ, M. JAROSOVA, J. VRBKOVÁ, T. PAPAJIK, K. INDRAK
Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experience. Neoplasma. 2015, 62(1), 146-151, ISSN: 0028-2685, PMID: 25563379,
BOUCHALOVÁ, K., G. KHARAISHVILI, J. BOUCHAL, J. VRBKOVÁ, M. HOUDOVÁ MEGOVÁ, A. HLOBILKOVA
Triple negative breast cancer-BCL2 in prognosis and prediction. Review. Current Drug Targets. 2014, 15(12), 1166-1175, ISSN: 1389-4501, PMID: 25374001,